buoyantintelligence
  • 01Overview
  • 02Portfolio
  • 03Company Atlas
    • Buoyant book
    • All listed companies
  • 04Screener & valuation
  • 05House view
  • 06Markets
  • 07India top-down
  • 08Investors
  • 09Library & data
Release
August 2026 · rev 1
Opportunities PMS · Published
As at 31 Aug 2026 · IST₹ · ₹ cr · BSE 500 TRI
Present
Internal working platform. Published figures are extracted from the August 2026 source package and reviewed; reference prices and fundamentals are unlicensed working data, not for redistribution. Past performance is not indicative of future returns.
All listed companies/Sudeep Pharma Limited
03 /Listed universe · Healthcare · Pharmaceuticals

Sudeep Pharma Limited.

Value itCompareScreener.in ↗Tijori ↗NSE ↗BSE ↗
Snapshot

Healthcare · Pharmaceuticals

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in India, the United States, and internationally. The company provides mineral salts, such as iron, calcium, sodium, zinc, copper, magnesium, manganese, potassium, picolinates, simethicone, and others;It also offers micronutrient premixes and liposomal, encapsulated ingredients, spray-dried formats, granulated ingredients, and triturated for sports nutrition, medical and clinical nutrition, infant nutrition, beverages, fortified staples, functional foods, and dairy products. In addition, the company provides a range of mineral powders and granules for carbonated, non-carbonated, and nutraceutical beverages; tricalcium phosphate, dicalcium phophate, dipotassium phosphate, ferric pyrophosphate, and disodium phosphate. Sudeep Pharma Limited was incorporated in 1989 and is based in Vadodara, India.

Market cap
₹13,540 cr
P/E (TTM)
73.9
P/B (latest)
15.3
ROE (TTM)
19.6%
ROCE (TTM)
24.3%
Sales CAGR 3y
14.4%
PAT CAGR 3y
40.5%
Debt / equity
0.17x
Promoter
76.2%
Dividend yield
0.13%
Size
Micro
Codes
SUDEEPPHRM · 544619
Price

₹1,195.2 · 29 Sept 2026

1M
+3.7%
3M
+45.6%
6M
+96.9%
YTD
+99.7%
1Y
—
3Y
—
5Y
—
vs 52w high
−11.1%

52-week ₹530 – ₹1,344.2 · ADTV ₹29.3 cr · price-only.

Trend

Sales and net profit by fiscal year, ₹ crore

Not in the Buoyant book: no house thesis or target is carried. Exchange masters, Tijori and the reference price feed as stated on each tab. All listed companies · NSE EQ